Among the many topics covered in the Q418/FY18 Surgical Matrices Market Recap are:
The US Surgical Matrices Market advanced again in Q218
In Q218, the US Surgical Matrices Market grew +9.5% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted strong growth in Q218...
Among the many topics covered in the Q218 US Surgical Matrices Recap are:
The US Surgical Matrices Market saw growth in Q317 as sales of allografts fueled double-digit growth in breast matrices and biosynthetics offset declines in biologics in hernia repair.
By Doug Devens, Senior Analyst Biosurgery
The US Surgical Matrices market, consisting of hernia repair and breast reconstruction products, continued uneven growth in Q317. Allergan continued to capture share in the overall market, using its growth in allografts to increase its share.
Continued Shift from Biologic to Synthetic Mesh
Innovation and clinical outcomes are shaping the future of the US ventral hernia market. Over the next several years, the market will see a continued shift from biologic mesh to synthetic mesh, growth in robotic hernia repairs, and an increased focus on clinical efficacy and economic outcomes data that will drive product adoption and impact market shares, particularly in the biosynthetic segment.